News & Updates

Use of machine learning (ML) can help pinpoint novel factors that contribute to an increased risk of atrial fibrillation (AF) in non-White patients with heart failure (HF), suggests a study. Specifically, social factors such as living alone may significantly heighten the AF risk.

Rosuvastatin is as effective as atorvastatin for the composite outcome of all-cause death, myocardial infarction (MI), stroke, or any coronary revascularization at 3 years in adults with coronary artery disease (CAD), according to the secondary analysis of the LODESTAR trial.

In the treatment of patients with methicillin-susceptible S aureus (MSSA)-associated infective endocarditis, the cefazolin is as good as cloxacillin, with similar mortality and relapse rates, according to a study.

A territory-wide, retrospective cohort study in Hong Kong has shown that dual antiplatelet therapy (DAPT) with ticagrelor is associated with a lower risk of major osteoporotic fractures (MOF) than clopidogrel in Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI).